04.06.2017 Views

Forbes_USA_June_13_2017

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

FORBES LIFE<br />

The Second<br />

Time Around<br />

When watch collector Pascal<br />

Raffy bought the venerable<br />

Swiss brand Bovet, he reinvented<br />

the company—and himself.<br />

BY ROBERTA NAAS<br />

By the age of 36, Pascal Raffy, a French<br />

pharmaceutical executive, was enjoying<br />

early retirement, spending time<br />

with his family and keeping an eye out<br />

for new investments. Knowing Raffy was a passionate<br />

watch collector, with hundreds of vintage<br />

timepieces, an investment banker friend would<br />

often tempt him with opportunities in the watch<br />

world. Each time, Raffy would decline—until one<br />

day his friend insisted Raffy do a blind touch test<br />

with a timepiece.<br />

“My friend put it, with several of my other<br />

watches, under a cloth,” Raffy recalls. “One by<br />

one, I felt those watches, and when my hand fell<br />

on one of them, I knew it was truly different. I felt<br />

the crown at the top of the strap and realized this<br />

was a watch with its own identity. Then I looked<br />

at it, and in a nanosecond it talked to me. I took<br />

my loupe and saw that it was a beautiful piece of<br />

horology. It had substance. I was interested.”<br />

And he had the means to make a significant<br />

investment. At 25, Raffy bought into a family-run<br />

French pharmaceuticals company, where, after a<br />

merger, he became head of the firm Synthélabo.<br />

After several successful years in France, Raffy expanded<br />

Synthélabo into North Africa, where he<br />

not only began the production of drugs but also<br />

built dedicated facilities for marketing and distributing<br />

them to doctors on the continent.<br />

During the ten years Raffy led Synthélabo, he<br />

turned it into the third-largest pharmaceutical<br />

group in France. But after his young daughter lamented<br />

that he worked too much, he decided to<br />

cash out. It took 18 months to organize the sale<br />

of Synthélabo to Sanofi, but Raffy wanted to leave<br />

the company in good hands. “Whenever you start<br />

something in an area of health and caring for<br />

human beings—where there is also a moral dimension<br />

in addition to the business side—it is<br />

very difficult to stop work,” he says.<br />

The retirement was short-lived once Raffy<br />

touched that watch under the cloth. The timepiece<br />

was made by Bovet. Swiss watchmaker Edouard<br />

Bovet had founded the brand in England<br />

in 1822, when the Silk Road was flourishing<br />

and there was demand in Asia for fine handmade<br />

pocket watches. Bovet’s earliest watches<br />

were hand-painted and created in identical pairs<br />

so if one watch needed to return to Europe for repair,<br />

the owner still had a fine watch to wear. The<br />

business operated out of England, but the watches<br />

were made in Fleurier, Switzerland, where they<br />

continued to be produced until the late 1930s.<br />

By 2000, when Raffy learned that Bovet was<br />

looking for a new investor, the two men who<br />

The art of time: “You<br />

should be able to<br />

take a loupe and<br />

know it is a Bovet,<br />

no matter the price,”<br />

says Raffy, wearing<br />

one of his Amadeo<br />

watches, which easily<br />

converts to a pocket<br />

watch or table clock<br />

(at right).<br />

PHOTOGRAPHS BY JAMEL TOPPIN FOR FORBES<br />

106 | FORBES JUNE <strong>13</strong>, <strong>2017</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!